Insurtechs Continue to Show Progress in 3Q, Expect Growth in 2025

Alignment Healthcare, Inc., Clover Health Investments Corp. and Oscar Health, Inc., which are commonly referred to as “insurtechs” for their focus on technology, each recently posted solid third-quarter financial results, especially compared with previous years.  

Ari Gottlieb, principal of health care consulting firm A2 Strategies and a longtime critic of some of the insurtechs, tells AIS Health that Alignment “has been a well-run business” for some time. He adds that Oscar and Clover “have turned into much better-run businesses” thanks to leadership changes and a narrower focus on where they compete in the market. Oscar last year hired industry veteran Mark Bertolini as CEO, while Clover last year promoted technology executive Andrew Toy to CEO.